Leadership Overview
BD has 10 executives leading key functions including finance, marketing, technology, and operations.
Driven by innovation, BD advances the world of health by improving medical discovery, diagnostics, and the delivery of care, supporting healthcare heroes with cutting-edge solutions.
Driven by innovation, BD advances the world of health by improving medical discovery, diagnostics, and the delivery of care, supporting healthcare heroes with cutting-edge solutions.
Leadership Roles at BD
Kathryn Wetzel - Chief of Staff & Chief Executive Officer, Office of & Senior VP
Kathryn Wetzel, the Chief of Staff & Chief Executive Officer, Office of & Senior VP at BD, provides strategic support and operational leadership across key company initiatives. This multifaceted role involves managing the Office of the CEO and driving critical projects that advance BD's mission. Wetzel ensures seamless coordination between executive leadership and operational teams, facilitating the delivery of innovative medical technologies. The Chief of Staff & Chief Executive Officer, Office of & Senior VP oversees strategic planning and execution, contributing to improvements in medical discovery, diagnostics, and care delivery. Kathryn Wetzel's leadership enhances organizational efficiency and supports the frontlines of healthcare by ensuring strategic alignment and effective resource deployment. This executive role is vital for driving BD's overall success and impact.
Shankar Ramamurthi - Vice President & Chief Financial Officer
Shankar Ramamurthi, the Vice President & Chief Financial Officer at BD, directs the company's financial strategy and operations. This leadership role involves managing all aspects of financial planning, accounting, and reporting to ensure fiscal health and support BD's mission of advancing global health. Ramamurthi oversees the allocation of resources, driving efficiency across departments and safeguarding the company's assets. The financial oversight provided by the Vice President & Chief Financial Officer is critical for enabling innovative medical technology development and supporting the frontlines of healthcare. This executive ensures that financial decisions align with BD's strategic objectives, fostering sustainable growth and operational excellence across its global footprint. Shankar Ramamurthi's expertise guides the company's financial trajectory, underpinning its commitment to improving medical discovery and patient care delivery.
Vitor Roque - Executive VP & Chief Financial Officer
Vitor Roque, the Executive VP & Chief Financial Officer at BD, provides overarching financial leadership and strategic direction for the company's global financial operations. This executive role involves managing complex financial structures, capital allocation, and investor relations to support BD's expansive mission. Roque oversees the financial health of the organization, ensuring robust fiscal management that enables continuous innovation in medical technology. The Executive VP & Chief Financial Officer drives financial planning and analysis, guiding investment decisions that advance medical discovery, diagnostics, and patient care delivery. Vitor Roque's strategic financial acumen is essential for navigating the global market and reinforcing BD's position as a leader in healthcare solutions. This leadership ensures financial stability and fuels the company's commitment to supporting healthcare professionals worldwide.
Ravi Dawar - Director, Finance & Chief Financial Officer
Ravi Dawar, the Director, Finance & Chief Financial Officer at BD, manages critical financial functions that underpin the company's operational success. This role focuses on detailed financial analysis, budgeting, and forecasting to support BD's strategic objectives in advancing healthcare. Dawar oversees financial reporting and compliance, ensuring adherence to regulatory standards while optimizing financial performance. The Director, Finance & Chief Financial Officer plays a key part in resource management, enabling the development and deployment of innovative medical technologies. Ravi Dawar's financial expertise contributes to the efficient delivery of care and supports the frontlines of healthcare by ensuring sound financial practices. This leadership ensures financial discipline and supports BD's mission to improve medical discovery and diagnostics globally.
Jillian Streeter - Manager, Quality & Chief Marketing Officer, Instrument
Jillian Streeter, the Manager, Quality & Chief Marketing Officer, Instrument at BD, spearheads the strategic marketing initiatives for BD's instrument division. This dual role encompasses ensuring the highest quality standards for instruments while driving market penetration and brand awareness. Streeter's responsibilities include developing and executing comprehensive marketing plans that highlight the innovative technology and solutions BD offers to healthcare providers. Overseeing market analysis and customer engagement, the Manager, Quality & Chief Marketing Officer, Instrument identifies opportunities for growth and product development. This leadership position is vital for translating technological advancements into market success, directly supporting BD's goal of improving medical discovery and diagnostics. Jillian Streeter's focus on quality and market strategy ensures BD's instrument offerings meet the evolving needs of the healthcare sector.
Florencia Amadeo - Chief Marketing Officer, Bd
Florencia Amadeo, the Chief Marketing Officer, Bd at BD, directs the company's comprehensive marketing strategies to enhance its global presence and impact. This executive role involves shaping the brand narrative and driving market engagement for BD's diverse portfolio of medical technologies. Amadeo oversees the development and execution of marketing campaigns that communicate the value of BD's solutions in improving medical discovery, diagnostics, and care delivery. The Chief Marketing Officer, Bd works to connect with healthcare providers and patients, articulating how BD supports the heroes on the frontlines. Florencia Amadeo's leadership ensures that BD's innovative technologies are effectively communicated, reinforcing the company's commitment to advancing health worldwide. This position is crucial for translating BD's mission into tangible market success.
Meera Gopalakrishnan - Senior VP & Global Chief Marketing Officer
Meera Gopalakrishnan, the Senior VP & Global Chief Marketing Officer at BD, leads the company's worldwide marketing efforts, shaping its brand identity and market strategy. This executive role involves overseeing global campaigns that highlight BD's commitment to advancing health through innovative medical technologies. Gopalakrishnan directs the communication of BD's impact on medical discovery, diagnostics, and the delivery of care, supporting healthcare professionals on the frontlines. The Senior VP & Global Chief Marketing Officer ensures that BD's solutions are effectively positioned to meet the evolving needs of the global healthcare landscape. Meera Gopalakrishnan's strategic vision drives market engagement and reinforces BD's mission to improve patient outcomes and clinical processes. This leadership is instrumental in expanding BD's reach and influence across international markets.
Elizabeth McCombs - Executive Vice President & Chief Technology Officer
Elizabeth McCombs, the Executive Vice President & Chief Technology Officer at BD, directs the company's technological vision and innovation pipeline. This critical role involves overseeing the development and implementation of cutting-edge technologies that advance medical discovery, diagnostics, and patient care. McCombs leads the research and development efforts, ensuring BD remains at the forefront of medical technology solutions. The Executive Vice President & Chief Technology Officer collaborates across departments to integrate new technologies that support healthcare providers and improve clinical processes. Elizabeth McCombs's leadership in technology is fundamental to BD's mission of improving health outcomes and supporting the heroes on the frontlines of healthcare. This executive drives the technological advancements that define BD's market leadership.
John DeFord - Executive Vice President & Chief Technology Officer
John DeFord, the Executive Vice President & Chief Technology Officer at BD, drives the strategic direction of the company's technological innovation and product development. This leadership position focuses on advancing BD's capabilities in medical discovery, diagnostics, and the delivery of care through pioneering technology. DeFord oversees the integration of new technologies that enhance clinical therapy for patients and streamline processes for healthcare providers. The Executive Vice President & Chief Technology Officer ensures that BD's technological investments align with its mission to improve global health outcomes. John DeFord's expertise in technology is crucial for maintaining BD's competitive edge and supporting the frontlines of healthcare with state-of-the-art solutions. This executive champions the technological advancements that underpin BD's commitment to health.
Devon Peterson - Director BD Excellence, Chief Revenue Officer
Devon Peterson, the Director BD Excellence, Chief Revenue Officer at BD, spearheads initiatives focused on revenue growth and operational excellence across the organization. This role involves optimizing sales strategies and enhancing customer value to drive BD's commercial success. Peterson oversees the implementation of BD Excellence programs, ensuring efficient and effective business processes that support the company's mission. The Director BD Excellence, Chief Revenue Officer plays a key part in aligning sales efforts with market demands, contributing to the advancement of medical discovery and diagnostics. Devon Peterson's focus on revenue generation and operational improvement directly supports BD's commitment to providing innovative solutions to healthcare providers worldwide. This leadership ensures sustained growth and market impact.
Explore Leadership Teams in Manufacturing
Orthofix is a global medical technology company based in Lewisville, Texas, focused on developing solutions for the treatment of musculoskeletal conditions. The company provides a broad range of medical technologies designed to improve patient outcomes, including spinal hardware, bone growth therapies, specialized limb reconstruction solutions, biologics, and enabling technologies, serving patients worldwide.
Company Leadership MC
CB
Lantheus is a healthcare technology company headquartered in Bedford, Massachusetts with additional offices in New Jersey, Canada, and Sweden. Founded in 1956, the company pioneers medical imaging technologies and provides innovative diagnostics, targeted therapeutics, and artificial intelligence solutions for healthcare. Lantheus specializes in developing software and health technologies that empower clinicians to effectively identify, treat, and monitor various diseases. The company maintains a diverse product portfolio focused on enhancing patient care through advanced medical imaging and diagnostic tools. As a publicly traded company since 2019, Lantheus continues to expand its global presence while maintaining its commitment to innovation in healthcare technology.
Company Leadership
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...
Company Leadership
WT
DR
DM
ROMTech® is thrilled to present our patented and groundbreaking rehabilitation technology, designed to serve a variety of orthopedic indications. Our revolutionary technology is improving patient outcomes, cutting cost of care, and overhauling the way postoperative orthopedic care is delivered.
Company Leadership GE
PL
MR
Frequently Asked Questions Regarding BD Top Executives and Leadership Team
